QIAGEN N.V. (QGEN) CEO to Ring the NASDAQ Stock Market Opening Bell

Company Celebrates 10 Year Listing Anniversary


MEDIA ADVISORY, June 28, 2006 (PRIMEZONE) --



 What:
 Mr. Peer Schatz, CEO of QIAGEN N.V. (QGEN) will preside over the
 opening bell to celebrate its 10 year listing anniversary on the
 NASDAQ.

 Where:
 NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast
 Studio

 When:
 Thursday June 29th, 2006 at 9:30 a.m. EDT

 Contacts:
 Dr. Solveigh K. Mahler
 Director, Investor Relations and Public Relations
 +49 151 180 11710
 solveigh.maehler@qiagen.com

 Dr. Thomas Theuringer
 Manager Public Relations
 +49 178-860 7269
 thomas.theuringer@qiagen.com

 NASDAQ MarketSite:
 Stephanie Lowenthal; 646.441.5220

Feed Information:

The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA-5 C-band/transponder 14. The downlink frequency is 3980 horizontal; audio: 6.2/6.8. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Stephanie Lowenthal at (646) 441-5220.

Photos:

To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.

About QIAGEN N.V. (QGEN):

QIAGEN is a leading provider of innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. QIAGEN has developed a comprehensive portfolio of more than 500 proprietary, consumable products and automated solutions for sample collection, and nucleic acid and protein handling, separation, and purification. QIAGEN also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics. The company's products are sold in more than 42 countries around the world to academic research markets, and to leading pharmaceutical and biotechnology companies, as well as to diagnostics laboratories. QIAGEN also provides purification and testing solutions to applied testing markets, such as forensics, animal or food testing, and pharmaceutical process control.